- €1.73bn
- €2.21bn
- €980.68m
- 94
- 35
- 68
- 77
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 835 | 855 | 615 | 751 | 981 |
Cost of Revenue | |||||
Gross Profit | 293 | 292 | 225 | 257 | 354 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 740 | 766 | 568 | 643 | 879 |
Operating Profit | 94.9 | 89.5 | 47.7 | 108 | 102 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 91.4 | 85.2 | 42.3 | 103 | 96 |
Provision for Income Taxes | |||||
Net Income After Taxes | 87.4 | 67.6 | 34 | 92.9 | 63.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 87.6 | 67.7 | 41.8 | 82 | 55.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 87.6 | 67.7 | 41.8 | 82 | 55.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.6 | 1.22 | 0.714 | 1.71 | 1.37 |